Showing 171-180 of 472 results for "".
Meet the MA Board: Elizabeth Bahar Houshmand, MD, FAAD
https://modernaesthetics.com/series/meet-the-board/meet-the-ma-board-elizabeth-bahar-houshmand/33819/Elizabeth Bahar Houshmand, MD, FAAD, shares her passion for dermatology, emphasizing her focus on treating patients of all ages for conditions such as hair loss, acne, and cosmetics. She attributes her success to her genuine love for her work and the satisfaction she derives from helping patients imMeet the MA Board: Alexander Z. Rivkin, MD
https://modernaesthetics.com/series/meet-the-board/meet-the-board-rivkin/33818/Alexander D. Rivkin, MD, shares valuable insights for aesthetic physicians looking to establish successful practices. Emphasizing the importance of keeping overhead costs low initially, Dr. Rivkin advises against taking out large loans for extravagant spaces at the start. He stresses the significancPsychosocial Aspect of Aging
https://modernaesthetics.com/conferences/tell-all-tribune/psychosocial-aspect-of-aging/33788/Shino Bay Aguilera, DO, emphasizes the importance of aging with integrity rather than despair or desperation, highlighting the significant impact of biological changes on the aging process, at the 2024 Tell-All Tribune: An Aesthetic Think Tank. Dr. Aguilera, a proponent of bioregenerative aestheticPsychology of an Aesthetic/Aging Patient
https://modernaesthetics.com/conferences/tell-all-tribune/psychology-of-an-aestheticaging-patient/33787/At the 2024 Tell-All Tribune: An Aesthetic Think Tank, Richard Fried, MD, PhD, FAAD, discusses how the relationship between patients and physicians is likened to a psychotherapeutic dance, with the patient's desires for acceptance, marketability, and satisfaction at the forefront. The quest for prejMATV News Extra: Daxxify Q&A with Dr. Jeffrey Dover
https://modernaesthetics.com/series/matv-news/matv-news-extra-daxxify-qa-with-dr-jeffrey-dover/33704/The FDA has approved Revance Therapeutics’ Daxxify (daxibotulinumtoxinA-lanm) for injection for the temporary improvement of moderate to severe glabellar lines in adults. Dermatologists and clinical trial investigator Jeffrey Dover, MD sat down with MATV News to share insights into the SAKURA PhaseA Cosmetic Surgery Boom
https://modernaesthetics.com/ma-podcasts/the-modern-aesthetics-podcast/a-cosmetic-surgery-boom/33930/New data from the American Society of Plastic Surgeons show business is good for aesthetic physicians. In fact, more than three-quarters of cosmetic-focused plastic surgery practices are seeing more business than before the pandemic. Bob Basu, MD, a plastic surgeon in Houston, TX, discusses the tMATV News: ASPS Stats, Upneeq Eyedrops for Ptosis; Allergan Acquires Soliton; The Beauty Health Company
https://modernaesthetics.com/series/matv-news/matv-news-asps-stats-upneeq-eyedrops-for-ptosis-allergan-acquires-soliton-the-beauty-health-company/33633/Annual statistics from the American Society of Plastic Surgeons predict an increased demand for cosmetic plastic surgery and non-surgical procedures and Wendy Lee, MD discusses the role for RVL’s Upneeq, a non-surgical option for ptosis, in aesthetic practices. Plus, Allergan Aesthetics acquires SolMATV News: COVID-19 Vaccine & Fillers; Allergan Aesthetics Could Acquire Cypris; Merz + Candela Partner to Expand Portfolio; New ASDS Stats
https://modernaesthetics.com/series/matv-news/matv-news-covid-19-vaccine-fillers-allergan-aesthetics-could-acquire-cypris-merz-candela-partner-to-expand-portfolio-new-asds-stats/33623/MATV News: Aesthetics experts weigh in on COVID-19 vaccine side effects in dermal filler patients, Allergan Aesthetics enters into option to acquire Cypris Medical and its Xact tool, Merz Aesthetics and Candela partner, to offer broad aesthetics portfolio, and new ASDS survey data show cosmetic procMATV News: ISHRS Public Awareness Campaign; Obagi Focuses on Diversity; AIS Updates
https://modernaesthetics.com/series/matv-news/matv-news-ishrs-public-awareness-campaign-obagi-focuses-on-diversiy-ais-updates/33482/ISHRS is launching a new public awareness campaign to help patients recognize “black market” hair restoration clinics, Obagi kicked off its Skinclusion initiative, and AIS attendees collaborate on the development and adoption of new aesthetic treatments and technologies. Plus, the FDA has accepted tMATV News: New ASAPS Leadership; Evaluating PRP; Improving Patient Follow Up; Silhouette Instalift Relaunch
https://modernaesthetics.com/series/matv-news/matv-news-new-asaps-leadership-evaluating-prp-improving-patient-follow-up-silhouette-instalift-relaunch/33273/The American Society for Aesthetic Plastic Surgery and the Aesthetic Surgery Education and Research Foundation name new presidents, researchers review studies on the safety and efficacy of platelet-rich plasma injection for facial rejuvenation and other cosmetic procedures, and eRelevance offers a n